UPDATE 2-U.S. FDA expands approval of Roche hemophilia drug
October 04, 2018 at 15:07 PM EDT
Roche on Thursday said U.S. regulators approved expanded use of its hemophilia A drug Hemlibra to include nearly all patients, as the Swiss drugmaker increases its focus on diseases beyond cancer to help replace revenue from older products that have lost patent protection.